Literature DB >> 28945189

Clostridium difficile colonization and infection in patients with hepatic cirrhosis.

Dong Yan1, Yunbo Chen1, Tao Lv1, Yandi Huang2, Jiezuan Yang1, Yongtao Li1, Jianrong Huang1, Lanjuan Li1.   

Abstract

OBJECTIVE: The aim of this study was to investigate the toxigenic Clostridium difficile colonization (CDC, colonization with toxigenic C. difficile but without symptoms) and C. difficile infection (CDI, active C. difficile infection resulting in disease symptoms) in hepatic cirrhosis patients, identify the risk factors of CDC, and determine the correlation between CDC and CDI.
METHODOLOGY: The strains of toxigenic C. difficile were isolated from patients with hepatic cirrhosis within 48 h after admission, followed by multilocus sequence typing (MLST). Patients were divided into toxigenic CDC group and noncolonized (NC) group according to the colonization. Logistic regression analysis was performed to analyse the risk factors for the CDC. Besides, the CDI incidence was compared between the two groups.
RESULTS: Colonization of toxigenic C. difficile was identified in 104 cases (19.8 %). Eighteen sequence types (STs) were identified, among which ST-3, ST-54, ST-35 and ST-37 were the predominant types. Child-Pugh class C(relative risk, RR, 3.025; 95 % CI: 1.410-6.488), decrease of prothrombin time activity (PTA) (RR 2.180; 95 % CI: 1.368-3.476), decrease of platelet (RR 2.746; 95 % CI: 0.931-8.103) and concurrent hepatic encephalopathy (RR 1.740; 95 % CI: 1.012-2.990) were identified as the risk factors for the hepatic cirrhosis patients with CDC. The CDI incidence in the CDC group was also significantly higher than that of the NC group (26.0 % vs 1.7 %, P<0.001).
CONCLUSION: An carriage rate of 19.8 % was reported in the hepatic cirrhosis patients with C. difficile colonization. Child's class C, decrease of PTA and platelet, and concurrent hepatic encephalopathy were the risk factors for the hepatic cirrhosis patients with C. difficile colonization. Hepatic cirrhosis patients with C. difficile colonization were more susceptible to CDI.

Entities:  

Keywords:  Clostridium difficile; Infection; colonization; hepatic cirrhosis; risk factor

Mesh:

Substances:

Year:  2017        PMID: 28945189     DOI: 10.1099/jmm.0.000596

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

Review 1.  Physical, Laboratory, Radiographic, and Endoscopic Workup for Clostridium difficile Colitis.

Authors:  Samantha J Baker; Daniel I Chu
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

2.  Characteristics of pathogenic bacteria in intra-abdominal infection and risk factors for septic shock in patients with liver cirrhosis.

Authors:  Yan Yan; Qiaoxia Ye; Liguan Liu
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

3.  Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection.

Authors:  Neven Papić; Fabijan Jelovčić; Marko Karlović; Lorna Stemberger Marić; Adriana Vince
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-28       Impact factor: 3.267

4.  Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients.

Authors:  Yunbo Chen; Hongqin Gu; Tao Lv; Dong Yan; Qiaomai Xu; Silan Gu; Ping Shen; Jiazheng Quan; Yunhui Fang; Lifeng Chen; Guangyong Ye; Lanjuan Li
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

5.  Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China.

Authors:  Yunbo Chen; Tao Lv; Dong Yan; Lisi Zheng; Beiwen Zheng; Jingxia Wang; Silan Gu; Lanjuan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-01       Impact factor: 6.073

6.  Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China.

Authors:  Danfeng Dong; Qi Ni; Chen Wang; Lihua Zhang; Zhen Li; Cen Jiang; Yibing Peng
Journal:  BMC Infect Dis       Date:  2018-05-03       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.